BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 16280329)

  • 1. The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1.
    Wu L; Nakano H; Wu Z
    J Biol Chem; 2006 Jan; 281(4):2162-9. PubMed ID: 16280329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
    Song YJ; Kang MS
    Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression.
    Kung CP; Raab-Traub N
    J Virol; 2010 Jul; 84(13):6605-14. PubMed ID: 20410275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique signaling properties of CTAR1 in LMP1-mediated transformation.
    Mainou BA; Everly DN; Raab-Traub N
    J Virol; 2007 Sep; 81(18):9680-92. PubMed ID: 17626074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.
    Luftig M; Prinarakis E; Yasui T; Tsichritzis T; Cahir-McFarland E; Inoue J; Nakano H; Mak TW; Yeh WC; Li X; Akira S; Suzuki N; Suzuki S; Mosialos G; Kieff E
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15595-600. PubMed ID: 14673102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-kappaB.
    Uemura N; Kajino T; Sanjo H; Sato S; Akira S; Matsumoto K; Ninomiya-Tsuji J
    J Biol Chem; 2006 Mar; 281(12):7863-72. PubMed ID: 16446357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BS69 cooperates with TRAF3 in the regulation of Epstein-Barr virus-derived LMP1/CTAR1-induced NF-kappaB activation.
    Ikeda O; Miyasaka Y; Yoshida R; Mizushima A; Oritani K; Sekine Y; Kuroda M; Yasui T; Fujimuro M; Muromoto R; Nanbo A; Matsuda T
    FEBS Lett; 2010 Mar; 584(5):865-72. PubMed ID: 20138174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
    Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of TNF receptor-associated factor 3 in signaling to B lymphocytes by carboxyl-terminal activating regions 1 and 2 of the EBV-encoded oncoprotein latent membrane protein 1.
    Xie P; Bishop GA
    J Immunol; 2004 Nov; 173(9):5546-55. PubMed ID: 15494504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
    Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LMP1 TRAFficking activates growth and survival pathways.
    Soni V; Cahir-McFarland E; Kieff E
    Adv Exp Med Biol; 2007; 597():173-87. PubMed ID: 17633026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines.
    Saito N; Courtois G; Chiba A; Yamamoto N; Nitta T; Hironaka N; Rowe M; Yamamoto N; Yamaoka S
    J Biol Chem; 2003 Nov; 278(47):46565-75. PubMed ID: 12968033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3.
    Kung CP; Raab-Traub N
    J Virol; 2008 Jun; 82(11):5486-93. PubMed ID: 18367518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.
    Edwards RH; Marquitz AR; Raab-Traub N
    mBio; 2015 Apr; 6(2):. PubMed ID: 25873381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms.
    Busch LK; Bishop GA
    J Immunol; 2001 Nov; 167(10):5805-13. PubMed ID: 11698454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAP-2 negatively regulates both canonical and noncanonical NF-kappaB activation induced by Epstein-Barr virus-derived latent membrane protein 1.
    Ikeda O; Sekine Y; Yasui T; Oritani K; Sugiyma K; Muromoto R; Ohbayashi N; Yoshimura A; Matsuda T
    Mol Cell Biol; 2008 Aug; 28(16):5027-42. PubMed ID: 18573890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.
    Shkoda A; Town JA; Griese J; Romio M; Sarioglu H; Knöfel T; Giehler F; Kieser A
    PLoS Biol; 2012; 10(8):e1001376. PubMed ID: 22904686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of Epstein-Barr virus latent membrane protein 1-mediated functions by the bone morphogenetic protein receptor IA-binding protein, BRAM1.
    Chung PJ; Chang YS; Liang CL; Meng CL
    J Biol Chem; 2002 Oct; 277(42):39850-7. PubMed ID: 12181323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1.
    Schultheiss U; Püschner S; Kremmer E; Mak TW; Engelmann H; Hammerschmidt W; Kieser A
    EMBO J; 2001 Oct; 20(20):5678-91. PubMed ID: 11598011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.